HighTower Advisors’s Cardiff Oncology CRDF Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $108K | Sell |
34,206
-7
| -0% | -$22 | ﹤0.01% | 3422 |
|
2025
Q1 | $107K | Hold |
34,213
| – | – | ﹤0.01% | 3317 |
|
2024
Q4 | $148K | Buy |
34,213
+18,880
| +123% | +$81.9K | ﹤0.01% | 3248 |
|
2024
Q3 | $41K | Sell |
15,333
-702
| -4% | -$1.88K | ﹤0.01% | 3372 |
|
2024
Q2 | $36K | Sell |
16,035
-1,965
| -11% | -$4.41K | ﹤0.01% | 3285 |
|
2024
Q1 | $96K | Buy |
18,000
+2,667
| +17% | +$14.2K | ﹤0.01% | 3126 |
|
2023
Q4 | $22K | Hold |
15,333
| – | – | ﹤0.01% | 3300 |
|
2023
Q3 | $21K | Hold |
15,333
| – | – | ﹤0.01% | 3250 |
|
2023
Q2 | $22K | Hold |
15,333
| – | – | ﹤0.01% | 3187 |
|
2023
Q1 | $25K | Hold |
15,333
| – | – | ﹤0.01% | 3050 |
|
2022
Q4 | $21K | Hold |
15,333
| – | – | ﹤0.01% | 3045 |
|
2022
Q3 | $23K | Buy |
+15,333
| New | +$23K | ﹤0.01% | 2893 |
|
2017
Q4 | – | Sell |
-25,500
| Closed | -$18K | – | 2148 |
|
2017
Q3 | $18K | Sell |
25,500
-40,100
| -61% | -$28.3K | ﹤0.01% | 2098 |
|
2017
Q2 | $84K | Buy |
65,600
+35,100
| +115% | +$44.9K | ﹤0.01% | 1979 |
|
2017
Q1 | $36K | Sell |
30,500
-75,000
| -71% | -$88.5K | ﹤0.01% | 1926 |
|
2016
Q4 | $223K | Buy |
105,500
+80,500
| +322% | +$170K | ﹤0.01% | 1624 |
|
2016
Q3 | $112K | Sell |
25,000
-23,500
| -48% | -$105K | ﹤0.01% | 1725 |
|
2016
Q2 | $219K | Sell |
48,500
-26,500
| -35% | -$120K | ﹤0.01% | 1452 |
|
2016
Q1 | $349K | Buy |
75,000
+50,000
| +200% | +$233K | ﹤0.01% | 1475 |
|
2015
Q4 | $135K | Sell |
25,000
-111,500
| -82% | -$602K | ﹤0.01% | 1811 |
|
2015
Q3 | $777K | Buy |
+136,500
| New | +$777K | 0.01% | 999 |
|